|
PRKAG1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.834200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.571600E-01 |
| Normal-vs-Stage2 |
3.269700E-02 |
| Normal-vs-Stage3 |
1.960840E-01 |
| Normal-vs-Stage4 |
3.087200E-01 |
| Stage1-vs-Stage2 |
1.955970E-02 |
| Stage1-vs-Stage3 |
9.179600E-02 |
| Stage1-vs-Stage4 |
2.256200E-01 |
| Stage2-vs-Stage3 |
1.864000E-03 |
| Stage2-vs-Stage4 |
6.861000E-03 |
| Stage3-vs-Stage4 |
9.398600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.130000E-01 |
| Normal-vs-AfricanAmerican |
5.064600E-01 |
| Normal-vs-Asian |
9.862200E-01 |
| Caucasian-vs-AfricanAmerican |
4.015600E-01 |
| Caucasian-vs-Asian |
7.374400E-01 |
| AfricanAmerican-vs-Asian |
5.966000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.278600E-01 |
| Normal-vs-Female |
8.522200E-01 |
| Male-vs-Female |
4.324600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.610400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.556600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.093800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.455200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.095000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.416200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.698200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.662000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.818000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.651200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.464030E-01 |
| Classical-VS-Follicular |
6.092400E-02 |
| Classical-VS-Other |
3.293000E-01 |
| Classical-VS-Normal |
9.203600E-01 |
| Tall-VS-Follicular |
6.904500E-03 |
| Tall-VS-Other |
8.054000E-01 |
| Tall-VS-Normal |
1.100590E-01 |
| Follicular-VS-Other |
1.999390E-01 |
| Follicular-VS-Normal |
1.149450E-01 |
| Other-VS-Normal |
2.335600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.272800E-01 |
| Normal-vs-N1 |
5.918200E-03 |
| N0-vs-N1 |
7.799900E-04 |
|
|
